Analytical Method Validation Toolkit

This toolkit highlights the most comprehensive information on analytical method validation and method development. With over 150 pages from the Journal of Validation Technology and the Journal of GXP Compliance, two hours of pre-recorded webinars, and thousands of slides from IVT's annual method validation conference, these products will ensure you keep abreast of ongoing method strategies and global regulatory trends.

BNDQ0005


$895.00


$995.00

Add Toolkit to Cart

Products in this Toolkit

| Special Edition | Product Code: SPEQ0002 | January 17, 2013 - 1:32 pm PST

Analytical Method Validation

Validating Immunoassays Using the Fluorescence Polarization Assay for the Diagnosis of Brucellosis David Gall and Klaus NielsenStep-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry Ghulam A. ShabirGood Analytical Method Validation Practice: Setting Up for Compliance and Efficiency: Part I Stephan O. Krause, Ph.D.Good Analytical Method Validation Practice: Deriving Acceptance Criteria for the AMV Protocol: Part II Stephan O. Krause, Ph.D.Download the entire 

| Special Edition | Product Code: SPEQ0003 | January 17, 2013 - 1:47 pm PST

Analytical Method Validation Volume II

Biological Method Validation A Practical Approach Cindy GreenDefining a Master Plan for the Validation of Analytical Methods Paul A. Winslow, Ph.D. and Richard F. Meyer, Ph.D.FDA and Industry Address Analytical Validation Issues for the Pharmaceutical Industry Jerry Lanese, Ph.D.Guidance for Industry Bioanalytical Methods Validation for Human Studies US Food and Drug Adminstration

| Conference Compendium | Product Code: CNFQ0005 | February 28, 2013 - 11:38 am PST

7th Annual Method Validation

FDA’s New Process Validation Guidance: How Can It Impact Test Method Validation? Jerry Lanese, Ph.D., President, The Lanese Group LLCEnsure Method Validation Compliance through Review of FDA Warning Letters David T. Lin, Ph.D., Senior Consultant, Biologics Consulting Group, Inc.  Enhancing Analytical Quality Through the Use of UPLC: One Method in Place of Two Corinne Mounier-Lee, Ph.D, Principal Scientist, Catalent Pharma SolutionsApplying QbD Based on Risk Assessment to Achieve a Fundamental & Practical Understanding of Method Validation Sue Mecham, Ph.D., Director of Laboratory...

| Product Code: VIDQ0001 | April 23, 2013 - 11:11 am PDT

Understanding the Challenges Behind QbD

In this 2009 webinar, Sam Venugopal discusses the results of CRADA's FDA-sponsored study on identifying the bottlenecks for implementation of quality by design (Qbd) in manufacturing facilities and opportunities for improvement.  Download "Understanding the Challenges Behind QbD – A Review of Leading Practices"

| Conference Compendium | Product Code: CNFQ0018 | July 11, 2013 - 7:49 am PDT

8th Annual Method Validation

Establish good documentation practices and acceptance criteriafor method validationOptimize methods and effectively communicate experimental resultsHandle deviations and variations during method validationDevelop change control processes during method validationReport your validation results—Streamline the processDevelop and validate of NIR/supervised principal component analysis methodsDiscover a new experimental approach for robustness experimentsDevelop and validate of chromatographic methodsValidate and verifiy of compendial methodsDownload the 8th Annual Method Validation AgendaDownload...

| Conference Compendium | Product Code: CNFQ0034 | August 12, 2013 - 8:37 am PDT

9th Annual Method Validation and Development

Hear directly from FDA and USP to Stay Abreast of Evolving Guidelines and RegulationsApply a QbD and Risk Management Approach to Method ValidationsLearn What is Needed to Update Your Methods to Today’s StandardExamine Different High Throughput Method Development StrategiesQualify Analytical InstrumentsDownload the 9th Annual Method Validation and Development AgendaDownload the 9th Annual Method Validation and Development Compendium

| Special Edition | Product Code: SPEQ0021 | October 7, 2013 - 12:02 pm PDT

Analytical Method Validation Volume III

Method Validation Studies: How GLP Interacts with Guidance Documents Steven S. Kuwahara, Ph.D.Reduction of Analytical Method Variability in an R&D Laboratory: A Case Study Briank K. Nunnally, Andre Johnson, and Raymond KaiseMethod Validation (for Medical Devices) Laure LarkinUse of Monte Carlo Simulation to Address CMC Issues Harry Yang, Ph.D.Validation of Dissolution Methods Gregory P. Martin and Vivian GrayUSP <1010> Analytical Data-Interpretaion and Treatment Appendix E: Comparison of Methods Lynn TorbeckAddressing Compliance Concerns During Dissolution Method Development, Validation,...

| Product Code: VIDQ0016 | October 7, 2013 - 12:16 pm PDT

Establishing a Valuable QbD Programme

Understand the regulators' expectations for QbDMake the business case for a QbD programUnderstand what new / additional expertise will be needed to:Establish a design spaceDescribe a design space in the submission.

Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.